Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 4
2012 1
2013 1
2014 2
2015 2
2016 3
2017 3
2018 1
2019 2
2020 7
2021 6
2022 12
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
Kwatra SG, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Lynde C, De Bruin-Weller MS, Nahm WK, Sauder M, Gharib R, Barbarot S, Szepietowski JC, Conrad C, Fleischer A, Laquer VT, Misery L, Serra-Baldrich E, Lapeere H, Ahmad F, Jabbar Lopez ZK, Piketty C, Ständer S; OLYMPIA 2 Investigators. Kwatra SG, et al. N Engl J Med. 2023 Oct 26;389(17):1579-1589. doi: 10.1056/NEJMoa2301333. N Engl J Med. 2023. PMID: 37888917 Clinical Trial.
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.
van Huizen AM, Menting SP, Gyulai R, Iversen L, van der Kraaij GE, Middelkamp-Hup MA, Warren RB, Spuls PI; SPIN MTX Consensus Survey Study Group; Schejtman AA, Egeberg A, Firooz A, Kumar AS, Oakley A, Foulkes A, Ramos AMC, Fougerousse AC, Carija A, Akman-Karakas A, Horváth B, Fábos B, Matlock BH, Claréus BW, Castro C, Ferrándiz C, Correa CC, Marchesi C, Goujon C, Gonzalez C, Maldonado-García C, Hong CH, Griffiths CEM, Vestergaard C, Echeverría CM, de la Cruz C, Conrad C, Törocsik D, Drvar DL, Balak D, Jullien D, Appelen D, Kim DH, de Jong EMGJ, El Gamal E, Laffitte E, Mahé E, Sonkoly E, Colombo EP, Vilarrasa E, Willaert F, Novoa FD, Handjani F, Valenzuela F, Vílchez-Márquez F, Gonzalez GO, Krisztián G, Damiani G, Krnjevic-Pezic G, Pellerano G, Carretero G, Hunter HJA, Riad H, Oon HH, Boonen HPJ, Moussa IO, García-Doval I, Csányi I, Brajac I, Turchin I, Grozdev I, Weinberg JM, Nicolopoulos J, Wells J, Lambert JLW, Ingram JR, Prinz JC, de Souza Sittart JA, Sanchez JL, Hsiao JP, Castro-Ayarza JR, Maul JT, van den Reek JMPA, Trcko K, Barber K, Reich K, Gebauer KA, Khobzei K, Maul LV, Massari LP, Fardet L, le Cleach L, Misery L, Chandrashekar L, Muresanu LI, Lecluse L, Skov L, F… See abstract for full author list ➔ van Huizen AM, et al. Among authors: carretero g. JAMA Dermatol. 2022 May 1;158(5):561-572. doi: 10.1001/jamadermatol.2022.0434. JAMA Dermatol. 2022. PMID: 35353175
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.
Lluch-Galcerá JJ, Carrascosa JM, González-Quesada A, Rivera-Díaz R, Sahuquillo-Torralba A, Llamas-Velasco M, Gómez-García FJ, Herrera-Acosta E, de la Cueva P, Baniandrés-Rodríguez O, Lopez-Estebaranz JL, Belinchón I, Ferrán M, Mateu A, Rodríguez L, Riera-Monroig J, Abalde-Pintos MT, Carretero G, García-Donoso C, Pujol-Marco C, Del Alcázar E, Santamaría-Domínguez C, Suárez-Pérez JA, Nieto-Benito LM, Ruiz-Genao DP, Salgado-Boquete L, Descalzo MÁ, García-Doval I. Lluch-Galcerá JJ, et al. Among authors: carretero g. Br J Dermatol. 2024 Feb 16;190(3):355-363. doi: 10.1093/bjd/ljad382. Br J Dermatol. 2024. PMID: 37846976
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting.
Daudén E, Escario E, Martos-Cabrera L, Armesto S, Herrera-Acosta E, Vidal D, Vilarrasa E, Rivera R, de la Cueva P, Martorell A, Ballesca F, Belinchón I, Carretero G, Rodríguez L, Romero-Maté A, Pujol-Montcusí J, Salgado L, Sahuquillo-Torralba A, Coto-Segura P, Baniandrés O, Feltes R, Riera-Monroig J, Garrido J, Llamas-Velasco M. Daudén E, et al. Among authors: carretero g. Int J Dermatol. 2024 Apr;63(4):503-511. doi: 10.1111/ijd.16915. Epub 2024 Jan 2. Int J Dermatol. 2024. PMID: 38168847
Comorbidity identification and referral in atopic dermatitis: a consensus document.
Ortíz de Frutos J, Carretero G, de Lucas R, Puig S, Serra E, Gómez Castro S, Rebollo Laserna F, Loza E, Silvestre-Salvador JF. Ortíz de Frutos J, et al. Among authors: carretero g. J Dermatolog Treat. 2022 Aug;33(5):2643-2653. doi: 10.1080/09546634.2022.2067815. Epub 2022 Apr 28. J Dermatolog Treat. 2022. PMID: 35435103
Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study.
López-Ferrer A, Vilarrasa E, Armesto S, Santos-Juanes J, Galache C, Carretero G, Sahuquillo A, Salgado-Boquete L, Del Alcázar E, González-Cantero A, Martorell A, Rivera-Díaz R, Mitxelena-Ezeiza J, Mateu A, Belinchón I, Llamas-Velasco M, Riera-Monroig J, Lázaro A, López-Estebaranz JL, Gich I, Puig L. López-Ferrer A, et al. Among authors: carretero g. Dermatol Ther. 2022 Nov;35(11):e15831. doi: 10.1111/dth.15831. Epub 2022 Sep 27. Dermatol Ther. 2022. PMID: 36109488 No abstract available.
Genome-wide association analysis of psoriasis patients treated with anti-TNF drugs.
Ovejero-Benito MC, Muñoz-Aceituno E, Sabador D, Almoguera B, Prieto-Pérez R, Hakonarson H, Coto-Segura P, Carretero G, Reolid A, Llamas-Velasco M, Abad-Santos F, Daudén E. Ovejero-Benito MC, et al. Among authors: carretero g. Exp Dermatol. 2020 Dec;29(12):1225-1232. doi: 10.1111/exd.14215. Epub 2020 Oct 29. Exp Dermatol. 2020. PMID: 33058233
43 results